
Chancellor George Osborne is giving UK drug R&D a £5 million vote of confidence, after promising new investment into two …

Manchester Science Parks (MSP), the new owners of the 400-acre Alderley Park facility, has pledged to keep its activities “at …

Half a dozen more bioscience companies are to become tenants at the Alderley Park BioHub in Cheshire, filling some of …

AstraZeneca has left a key question about what to do with its soon-to-be defunct R&D site in Cheshire in the …
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions

